PGR and neoplasm: No statistically significant association was noted between PD-L1 expression, PgR, Her-2/neu, and clinicopathological parameters, namely age, clinical features, menstrual history, tumor grade, tumor size, pTNM, lymph node metastases, and extranodal extension.